92 related articles for article (PubMed ID: 19396750)
1. WHO fracture risk calculator (FRAX) in the assessment of obese patients with osteoporosis.
Franek E; Wichrowska H; Gozdowski D; Puzianowska-Kuźnicka M
Endokrynol Pol; 2009; 60(2):82-7. PubMed ID: 19396750
[TBL] [Abstract][Full Text] [Related]
2. Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.
Yu SF; Chen JF; Chen YC; Lai HM; Ko CH; Chiu WC; Su FM; Hsu CY; Su BY; Wu CH; Cheng TT
Medicine (Baltimore); 2017 Feb; 96(5):e5959. PubMed ID: 28151883
[TBL] [Abstract][Full Text] [Related]
3. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
4. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
Watts NB
J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
[TBL] [Abstract][Full Text] [Related]
5. A discussion of the intervention thresholds in osteoporosis treatment in Poland.
Marcinkowska M; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Marcinkowska WH; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Horst-Sikorska W
Endokrynol Pol; 2011; 62(1):30-6. PubMed ID: 21365576
[TBL] [Abstract][Full Text] [Related]
6. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
[TBL] [Abstract][Full Text] [Related]
7. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of osteoporotic fractures in the group of woman over 50 years of age--comparison of tools FRAX BMD versus FRAX BMI].
Strugala C; Sobala W; Szubert Z; Hanke W
Med Pr; 2013; 64(3):327-33. PubMed ID: 24261246
[TBL] [Abstract][Full Text] [Related]
9. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.
Watts NB; Lewiecki EM; Miller PD; Baim S
J Clin Densitom; 2008; 11(4):473-7. PubMed ID: 18562228
[No Abstract] [Full Text] [Related]
10. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
[TBL] [Abstract][Full Text] [Related]
11. [FRAX fracture risk calculator in the diagnostics and treatment of osteoporosis].
Kröger H
Duodecim; 2013; 129(11):1149-52. PubMed ID: 23819200
[TBL] [Abstract][Full Text] [Related]
12. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
13. Defining bone health and fracture risk in West Virginia: the World Health Organization FRAX assessment tool.
Shuler FD; Conjeski J
W V Med J; 2011; 107(5):12-7. PubMed ID: 22034804
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
Badurski J; Jeziernicka E; Dobreńko A; Nowak N; Daniluk S; Rybaczuk M; Wiśniowiecka M
Endokrynol Pol; 2011; 62(4):290-8. PubMed ID: 21879467
[TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
16. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
Dhanapal V; Reeves DJ
J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
[TBL] [Abstract][Full Text] [Related]
17. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
[TBL] [Abstract][Full Text] [Related]
19. Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk.
Grover ML; Edwards FD; Chang YH; Cook CB; Behrens MC; Dueck AC
Womens Health Issues; 2014; 24(1):e69-75. PubMed ID: 24439949
[TBL] [Abstract][Full Text] [Related]
20. Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis.
Gonzalez-Lopez L; Gamez-Nava JI; Vega-Lopez A; Rodriguez-Jimenez NA; Gonzalez-Montoya N; Aguilar-Chavez E; Alcaraz-Lopez MF; Rocha-Muñoz AD; Castro-Lizano N; Morales-Romero J; Salazar-Paramo M; Suarez-Almazor ME
J Rheumatol; 2012 Feb; 39(2):247-53. PubMed ID: 22174197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
